★ Analysts see FY2026 revenue reaching $983M — +7.7% growth in a single year.
What Moves the Stock
01Annual reimbursement rate negotiations with French regional health agencies (ARS), typically concluded Q1-Q2, which directly impact 70%+ of revenue
02Occupancy rate trends across the facility portfolio, with 90%+ considered healthy and sub-88% signaling demand or operational issues
03Labor cost inflation and ability to recruit/retain qualified nursing staff amid France's healthcare worker shortage
04New facility openings or acquisitions that expand bed capacity and geographic footprint
05Changes to French long-term care regulations, including staffing ratio requirements and quality standards that affect operating costs
06Elderly care facilities (EHPAD - nursing homes) representing estimated 70-75% of revenue, funded primarily through French social security reimbursements
07Psychiatric and post-acute care clinics representing estimated 20-25% of revenue, with higher private pay mix
08Ancillary services including rehabilitation, memory care units, and specialized dementia programs representing remaining 5-10%
value - The 0.3x price/sales, 0.8x price/book, and 26.4% FCF yield suggest deep value characteristics attracting contrarian investors…
Moderate sensitivity through two channels: (1) Financing costs on the 2.83x debt/equity capital structure…
Watch on earnings: French healthcare sector wage agreements and minimum wage (SMIC) increases that drive 60-65% of operating costs, Regional health agency (ARS) budget allocations and reimbursement rate guidance published annually by French Ministry of Health, French demographic trends: population aged 75+ and dependency ratios indicating long-term demand trajectory.
One Sentence Summary:
LNA Santé: the story is balanced — annual reimbursement rate negotiations with french regional health agencies (ars), typically concluded q1-q2.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.
